Evidence map›Paper›PMID 33517909›Full record

ArticleBreast cancer research : BCR2021

Effects of neoadjuvant chemotherapy on the contralateral non-tumor-bearing breast assessed by diffuse optical tomography.

Mirella L Altoe, Kevin Kalinsky, Alessandro Marone, Hyun K Kim, Hua Guo, Hanina Hibshoosh, Mariella Tejada, Katherine D Crew, Melissa K Accordino, Meghna S Trivedi and 2 more

Open access · goldAbstract read
In one paragraph

Article in Breast cancer research : BCR, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Mirella L AltoeDepartments of Biomedical Engineering, New York University Tandon School of Engineering, Brooklyn, NY, 11201, USA.ORCID 0000-0002-8282-6038
Kevin KalinskyDepartment of Medicine, Division of Hematology/Oncology, Columbia University Irving Medical Center, New York, NY, 10032,, USA.
Alessandro MaroneDepartments of Biomedical Engineering, New York University Tandon School of Engineering, Brooklyn, NY, 11201, USA.
Hyun K KimDepartments of Biomedical Engineering, New York University Tandon School of Engineering, Brooklyn, NY, 11201, USA.
Hua GuoDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, 10032, USA.
Hanina HibshooshDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, 10032, USA.
Mariella TejadaDepartment of Medicine, Division of Hematology/Oncology, Columbia University Irving Medical Center, New York, NY, 10032,, USA.
Katherine D CrewDepartment of Medicine, Division of Hematology/Oncology, Columbia University Irving Medical Center, New York, NY, 10032,, USA.
Melissa K AccordinoDepartment of Medicine, Division of Hematology/Oncology, Columbia University Irving Medical Center, New York, NY, 10032,, USA.
Meghna S TrivediDepartment of Medicine, Division of Hematology/Oncology, Columbia University Irving Medical Center, New York, NY, 10032,, USA.
Dawn L HershmanDepartment of Medicine, Division of Hematology/Oncology, Columbia University Irving Medical Center, New York, NY, 10032,, USA.
Andreas H HielscherDepartments of Biomedical Engineering, New York University Tandon School of Engineering, Brooklyn, NY, 11201, USA. ahh4614@nyu.edu.
Columbia University Irving Medical Center · USNew York University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe purpose of this study is to evaluate whether the changes in optically derived parameters acquired with a diffuse optical tomography breast imager system (DOTBIS) in the contralateral non-tumor-bearing breast in patients administered neoadjuvant chemotherapy (NAC) for breast cancer are associated with pathologic complete response (pCR).

methodsIn this retrospective evaluation of 105 patients with stage II-III breast cancer, oxy-hemoglobin (ctO

resultsPatients who achieved pCR to NAC had an overall decrease of 3.88 μM for ctO

conclusionsThis study demonstrates that the contralateral normal breast tissue assessed by DOTBIS is modifiable after NAC, with changes associated with pCR after only 2-3 weeks of chemotherapy.

Indexed as

Tomography, OpticalAlgorithmsAntineoplastic Combined Chemotherapy ProtocolsBiomarkers, TumorBreast NeoplasmsDisease ManagementFemaleHumansImage Processing, Computer-AssistedNeoadjuvant TherapyTreatment OutcomeTumor BurdenBiomarkers, TumorBreast cancerContralateral breastDiffuse optical tomographyMenopausal statusNACpCR

Identifiers

PMID33517909
PMCPMC7849076
OpenAlexW3128954105

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.